A 12-week, Multicentre, Multinational, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster 100/6 (Beclomethasone Dipropionate 100 microg Plus Formoterol 6 microg/Actuation), 2 Puffs b.i.d., Versus Seretide 500/50 (Fluticasone 500 microg Plus Salmeterol 50 microg/Actuation), 1 Inhalation b.i.d., in Patients With Chronic Obstructive Pulmonary Disease.

Trial Profile

A 12-week, Multicentre, Multinational, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster 100/6 (Beclomethasone Dipropionate 100 microg Plus Formoterol 6 microg/Actuation), 2 Puffs b.i.d., Versus Seretide 500/50 (Fluticasone 500 microg Plus Salmeterol 50 microg/Actuation), 1 Inhalation b.i.d., in Patients With Chronic Obstructive Pulmonary Disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Acronyms FUTURE
  • Most Recent Events

    • 26 May 2012 Additional locations (Germany, Hungary, Poland, United Kingdom) added as reported by European Clinical Trials Database record.
    • 02 Apr 2012 Actual patient number is 373 according to ClinicalTrials.gov.
    • 02 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top